## **Core Concept**
The question targets the treatment of *Mycobacterium leprae*, the causative organism of leprosy. Leprosy, also known as Hansen's disease, is a chronic bacterial infection primarily affecting the skin, the peripheral nerves, mucosa of the upper respiratory tract, and the eyes. The most effective treatment for leprosy involves multidrug therapy (MDT) as recommended by the World Health Organization.

## **Why the Correct Answer is Right**
The correct answer, **C. Rifampicin**, is a key component of the multidrug therapy for leprosy. Rifampicin is a potent bactericidal agent against *M. leprae*, working by inhibiting RNA synthesis. It is highly effective in killing the bacteria quickly, thus preventing further transmission and progression of the disease. The use of rifampicin has significantly reduced the treatment duration and improved outcomes in leprosy patients.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although it might represent another antibiotic, its effectiveness against *M. leprae* is not as pronounced as rifampicin.
- **Option B:** This option is incorrect as it does not represent a commonly recognized first-line treatment for leprosy.
- **Option D:** This option is incorrect because, similar to option A, it does not represent the most effective drug against *M. leprae*.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that the multidrug therapy (MDT) for leprosy, as recommended by the WHO, includes rifampicin, dapsone, and clofazimine. Among these, **rifampicin is considered the most potent bactericidal agent against *M. leprae***. This combination is crucial for preventing drug resistance and ensuring the effective treatment of leprosy.

## **Correct Answer:** C. Rifampicin